Jana L. Jacobs

1.9k total citations
34 papers, 877 citations indexed

About

Jana L. Jacobs is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Jana L. Jacobs has authored 34 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 12 papers in Virology and 10 papers in Molecular Biology. Recurrent topics in Jana L. Jacobs's work include HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Jana L. Jacobs is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Jana L. Jacobs collaborates with scholars based in United States, Philippines and United Kingdom. Jana L. Jacobs's co-authors include Carolyn B. Coyne, John W. Mellors, Kevin D. McCormick, Ghady Haidar, Joshua C. Cyktor, Elias K. Halvas, Kemp B. Cease, Jon Oscherwitz, Saumendra N. Sarkar and Jianzhong Zhu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jana L. Jacobs

30 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana L. Jacobs United States 16 438 290 273 222 175 34 877
Wei Zou China 14 263 0.6× 208 0.7× 366 1.3× 226 1.0× 143 0.8× 25 794
Alexandra M. Ortiz United States 14 355 0.8× 325 1.1× 530 1.9× 335 1.5× 243 1.4× 38 1.0k
Elizaveta Starodubova Russia 13 178 0.4× 266 0.9× 196 0.7× 179 0.8× 152 0.9× 43 736
José V. Torres United States 16 336 0.8× 302 1.0× 302 1.1× 211 1.0× 167 1.0× 46 834
Jennifer A. Fulcher United States 19 478 1.1× 560 1.9× 227 0.8× 428 1.9× 347 2.0× 43 1.4k
Fedde Groot Netherlands 13 278 0.6× 215 0.7× 621 2.3× 434 2.0× 157 0.9× 14 920
Susan Pereira Ribeiro United States 16 209 0.5× 178 0.6× 390 1.4× 364 1.6× 165 0.9× 29 740
Lara Doyle‐Meyers United States 16 471 1.1× 140 0.5× 146 0.5× 301 1.4× 230 1.3× 45 959
Binhua Ling United States 19 336 0.8× 183 0.6× 750 2.7× 397 1.8× 315 1.8× 40 1.1k
Julie Czartoski United States 11 356 0.8× 163 0.6× 512 1.9× 406 1.8× 150 0.9× 15 890

Countries citing papers authored by Jana L. Jacobs

Since Specialization
Citations

This map shows the geographic impact of Jana L. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana L. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana L. Jacobs more than expected).

Fields of papers citing papers by Jana L. Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana L. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana L. Jacobs. The network helps show where Jana L. Jacobs may publish in the future.

Co-authorship network of co-authors of Jana L. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Jana L. Jacobs. A scholar is included among the top collaborators of Jana L. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana L. Jacobs. Jana L. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capoferri, Adam A., Ann Wiegand, Feiyu Hong, et al.. (2024). HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA. Proceedings of the National Academy of Sciences. 121(36). e2405210121–e2405210121. 3 indexed citations
2.
Heaps, Amy, Michele D. Sobolewski, Jana L. Jacobs, et al.. (2023). Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer. Journal of Virological Methods. 316. 114726–114726.
3.
Jacobs, Jana L., et al.. (2023). TIM-3 signaling contributes to the suppressive capacity of Tregs from people with HIV on antiretroviral therapy. Journal of Leukocyte Biology. 114(4). 368–372. 1 indexed citations
4.
Jacobs, Jana L., Asma Naqvi, Faraaz Shah, et al.. (2022). Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19. The Journal of Infectious Diseases. 226(12). 2089–2094. 11 indexed citations
5.
Brandt, Leah D., Shuang Guo, Jana L. Jacobs, et al.. (2021). Tracking HIV-1-Infected Cell Clones Using Integration Site-Specific qPCR. Viruses. 13(7). 1235–1235. 10 indexed citations
6.
Jacobs, Jana L., William Bain, Ernesto T. A. Marques, et al.. (2021). COVID-19 outcome: Insights from quantification of viremia and neutralizing antibody. 29(1). 30–31.
7.
Halvas, Elias K., Leah D. Brandt, Shuang Guo, et al.. (2020). HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus. Journal of Clinical Investigation. 130(11). 5847–5857. 87 indexed citations
8.
Jacobs, Jana L., Dianna Koontz, Andrew Worlock, et al.. (2020). Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy. Journal of Clinical Microbiology. 58(12). 10 indexed citations
9.
Jacobs, Jana L. & John W. Mellors. (2020). Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean?. Clinical Infectious Diseases. 2 indexed citations
10.
McCormick, Kevin D., John W. Mellors, & Jana L. Jacobs. (2020). Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2. Current Opinion in HIV and AIDS. 16(1). 3–10. 2 indexed citations
11.
Jacobs, Jana L., et al.. (2019). Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms. Frontiers in Microbiology. 10. 2383–2383. 33 indexed citations
12.
Hong, Feiyu, Jana L. Jacobs, Evgenia Aga, et al.. (2018). Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy. Virology. 521. 51–57. 15 indexed citations
13.
Jacobs, Jana L., Jianzhong Zhu, Saumendra N. Sarkar, & Carolyn B. Coyne. (2013). Regulation of Mitochondrial Antiviral Signaling (MAVS) Expression and Signaling by the Mitochondria-associated Endoplasmic Reticulum Membrane (MAM) Protein Gp78. Journal of Biological Chemistry. 289(3). 1604–1616. 37 indexed citations
14.
Oscherwitz, Jon, et al.. (2013). Recombinant Vaccine Displaying the Loop-Neutralizing Determinant from Protective Antigen Completely Protects Rabbits from Experimental Inhalation Anthrax. Clinical and Vaccine Immunology. 20(3). 341–349. 17 indexed citations
15.
Jacobs, Jana L. & Carolyn B. Coyne. (2013). Mechanisms of MAVS Regulation at the Mitochondrial Membrane. Journal of Molecular Biology. 425(24). 5009–5019. 157 indexed citations
16.
Oscherwitz, Jon, et al.. (2009). Synthetic Peptide Vaccine Targeting a Cryptic Neutralizing Epitope in Domain 2 ofBacillus anthracisProtective Antigen. Infection and Immunity. 77(8). 3380–3388. 26 indexed citations
17.
Oscherwitz, Jon, et al.. (2008). Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors. Molecular Therapy. 17(2). 373–379. 16 indexed citations
18.
Heyl, Deborah, et al.. (2005). Correlation of LUMO localization with the α-amylase inhibition constant in a Tendamistat-based series of linear and cyclic peptides. Bioorganic & Medicinal Chemistry. 13(13). 4262–4268. 7 indexed citations
19.
Granoff, D. M., Janardan P. Pandey, Moon H. Nahm, et al.. (1989). Host and Bacterial Factors Associated with Haemophilus influenzae Type b Disease in Minnesota Children Vaccinated with Type b Polysaccharide Vaccine. The Journal of Infectious Diseases. 159(5). 908–916. 23 indexed citations
20.
Price, Donald B., Jana L. Jacobs, Jack O. Haller, et al.. (1988). Pediatric AIDS. Pediatric Radiology. 18(6). 445–448. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Zou Breakdown of academic impact, for papers by Alexandra M. Ortiz Breakdown of academic impact, for papers by Elizaveta Starodubova Breakdown of academic impact, for papers by José V. Torres Breakdown of academic impact, for papers by Jennifer A. Fulcher Breakdown of academic impact, for papers by Fedde Groot Breakdown of academic impact, for papers by Susan Pereira Ribeiro Breakdown of academic impact, for papers by Lara Doyle‐Meyers Breakdown of academic impact, for papers by Binhua Ling Breakdown of academic impact, for papers by Julie Czartoski
Rankless by CCL
2026